Substance Use During COVID-19 Among Those Recovering from Opioid Use Disorder

To identify individual-level factors associated with COVID-19-related impacts on recovery in 216 participants originally enrolled in the SUBLOCADE® (buprenorphine extended-release) clinical program. 

Within the fifteen-month study 216 participants, during the period of September 2021 through January 2021, were asked how the COVID-19 crisis affected their recovery from substance use, utilizing self-reported measures. What are the main findings?

Response: About a quarter of the participants reported that COVID-19 had made recovery somewhat or much harder. These participants were also more likely to report increased past-month opioid use rate. What should readers take away from your report?

Response: This study underscores the importance of monitoring those in recovery from opioid use disorder (OUD), particularly during times of crisis or decreased access to timely healthcare.

Citation:Tegge et al. Struggling with Recovery from, Opioids:  Who is at Risk During COVID-19.; Presented at College on Problems of Drug Dependence (CPDD), Late Breaking Oral Presentation II-COVID; June 21, 2021.

Sponsored by Indivior 

The information on is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.


Last Updated on June 24, 2021 by Marie Benz MD FAAD